(S)-1-METHOXY-2-PROPYLAMINE, 95%, 1g

2,3-Dihydrobenzofuran-7-amine, 95.0%, 250mg

(2E)-3-(2-methylphenyl)-1-(4-methylphenyl)prop-2-en-1-one, 95.0%, 10g

2-Methoxy-5-methylphenylacetic acid, 95.0%, 250mg

3-Fluoro-4-pyridinecarboxylic acid, 98.0%, 5g

2,6-Bis[(4R,5R)-4,5-dihydro-4,5-diphenyl-1H-imidazol-2-yl]pyridine, 97%,99% ee, 250mg

Asa de inoculación, Ojos Ø 4,0 mm, 50 mm 10 uds.

1-(1-isobutyrylpiperidin-4-yl)methanamine, 95.0%, 1g

Monomethyl Maleate>90.0%(GC)500mL

Sodium 2'-(dicyclohexylphosphino)-2,6-diisopropylbiphenyl-4-sulfonate, 97%, 250mg

11-Methoxy-11-oxoundecanoic acid, 95.0%, 100g

VADADUSTAT, 97%, 50mg

2-Bromo-4-methyl-5-nitroanisole, 95+%, 250mg